• +41 91 682 20 40
  • info@elixi-int.com
  • Reserved Area
    • Login
    • Register
    • Request Document
    • Send Document
logo
  • Home
  • About Us
  • Services
  • Quality
  • News
  • Case Studies
  • Contact
  • Online Store

Let's talk

info@yourwebsite.com
+1 (555) 123-4567

  • Search

rheumatoid arthritis

3 November 2021

Cyltezo(adalimumab-adbm), the First Interchangeable Biosimilar to Humira

by Elixi

2 October 2020

Jyseleca (filgotinib), approved in the EU for the treatment of adults with moderate to severe rheumatoid arthritis

by Elixi

18 September 2020

New indication for Olumiant (baricitinib) as oral treatment for moderate to severe atopic dermatitis

by Elixi